Seth Ginsberg: Educating Patients on Biosimilars

Seth Ginsberg, co-founder and president of the Global Healthy Living Foundation, reflects on physician efforts to educate patients about biosimilars.
January 15, 2018


Transcript:

Do physicians do a good enough job of educating patients about biosimilars versus biologics?

Since I’m not a doctor—although sometimes I like to joke that I could play one on the Internet—I cannot speak to their overall education about biosimilars versus biologics. But my impression, based on speaking with many rheumatologists and other doctors, is that they’re taking a wait-and-see approach before prescribing biosimilars.
 

x-button

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.